NEUROCRINE BIOSCIENCES INC (NBIX)

US64125C1099 - Common Stock

131.06  +0.41 (+0.31%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
1.134B
8.38%
1.489B
31.34%
1.887B
26.76%
2.212B
17.22%
EBITDA
YoY % growth
218.7M
-34.93%
266.3M
21.76%
416.1M
56.25%
616.5M
48.16%
EBIT
YoY % growth
207.8M
-36.55%
250.7M
20.64%
394.8M
57.48%
620.89M
57.27%
Operating Margin
18.33%16.84%20.92%28.07%
EPS
YoY % growth
1.32
1.54%
1.53
15.91%
2.42
58.17%
4.74
95.73%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
1.00
226.15%
Revenue
Q2Q % growth
524.42M
24.74%
EBITDA
Q2Q % growth
147.2M
EBIT
Q2Q % growth
118.31M
298.35%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth
1.44
63.64%
1.170.2723.28%
Q3 2023
Q2Q % growth
0.82
18.84%
0.99-0.17-16.79%
Q2 2023
Q2Q % growth
0.95
627.78%
0.790.1619.84%
Q1 2023
Q2Q % growth
-0.79
-664.29%
0.13-0.92-697.25%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth
515.2M
25.05%
528.84M-13.64M-2.58%
Q3 2023
Q2Q % growth
498.8M
28.59%
479.9M18.9M3.94%
Q2 2023
Q2Q % growth
452.7M
19.70%
456.25M-3.55M-0.78%
Q1 2023
Q2Q % growth
420.4M
35.35%
417.45M2.95M0.71%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-8.03% 0.81% 0.92% -3.5%
Revenue0.39% 0.88% -0.09% 1.98%